Last update 01 Nov 2024

C-13-60

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms-
Target
Mechanism
CEA inhibitors(Carcinoembryonic antigen inhibitors), Immunologic cytotoxicity, T lymphocyte replacements
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 2
CN
07 Jun 2022
Colonic CancerPhase 2
CN
07 Jun 2022
Esophageal CarcinomaPhase 2
CN
07 Jun 2022
Rectal CancerPhase 2
CN
07 Jun 2022
Breast CancerPhase 2
CN
20 Feb 2020
Lung CancerPhase 2
CN
20 Feb 2020
Pancreatic CancerPhase 2
CN
20 Feb 2020
Stomach CancerPhase 2
CN
20 Feb 2020
Recurrent CarcinomaPreclinical
CN
20 Feb 2020
Liver CancerDiscovery
CN
20 Feb 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
Solid tumor
Third line
40
(intravenous)
(ggprydxwsh) = pppedlrxbf ulfbzmehxh (vrodbwaolq )
Positive
24 May 2024
(intravenous + Low Dose)
(ggprydxwsh) = xwcteqdepe ulfbzmehxh (vrodbwaolq )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free